- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06566027
Activator vs the EF Class II Standard in the Treatment of Severe Overjet in Angle Class II Division 1 Malocclusion
A Comparison of the Effectiveness of Activator Versus the EF (Functional Education) Class II Standard in the Treatment of Severe Overjet in Angle Class II Division 1 Malocclusion in Vietnamese Population: A Randomized Controlled Trial
Objective: The purpose of this study was to compare the clinical effectiveness of reducing severe overjet in Angle Class II division 1 malocclusion between Activator and the EF (Functional Education) class II standard in treating.
Methods: A randomized clinical trial was conducted on a total of ̉60 patients with an Angle Class II, division 1 malocclusion (ANB angle ≥ 4°, basic normal maxillary status), and an overjet of ≥ 6 mm in the developmental stage (CS1-CS3) who were eligible for the study. Thus, the sample consisted of 60 subjects (29 girls and 31 boys) with a mean age of 9.7 ± 1.31 years. The investigators designed the study to treat patients, randomly assigning them by lottery to receive either an activator or the EF (Functional Education) class II standard. The activator versus the EF (Functional Education) class II standard group consisted of 30 subjects (17 girls, 13 boys) and 30 subjects (12 girls, 18 boys), respectively. The changes in skeletal, dental, and soft tissue were recorded before, at 6 months of treatment. Blinding was not performed. After six months of treatment, the study's endpoint was reached.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ho Chi Minh City, Vietnam
- Department of Orthodontics, Ho Chi Minh City Dental Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Vietnamese children between the ages of 7 and 12 with central incisors erupted
- Angle Class II division 1 malocclusion (ANB angle ≥ 4°, basic normal maxillary status)
- Severe overjet ≥ 6mm
- The developmental stage (CS1-CS3)
- No previous orthodontic treatment
- Agreeing to engage in the study
Exclusion Criteria:
- The young with crossbite
- Severe crowding
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Skeletal, dental, soft tissue index changes in Activator group
Activator The researcher made wax impressions of the study's patients for both the activator and treatment monitoring.
The researcher instructed the patients to use the activator device for 12-14 hours daily, with a minimum requirement of 12 hours.
Precise ablation of the activator created plastic surfaces that guided the process of tooth eruption.
|
After being interviewed and provided by a doctor with two kinds of appliances (Activator and EF class II standard) for treating class II malocclusion, the patients choose their appliance.
The patients were separated into two groups (30 in each).
Group 1 was treated with an Activator appliance (Activator group), whereas Group 2 was treated with an EF class II standard appliance (EF line group)
|
|
Experimental: Skeletal, dental, soft tissue index changes in EF class II standard group
EF class II standard The researcher monitored the study children through therapy.
The research used four types of EF class II standard appliances (Orthoplus, France).
Patients were required to wear the EF class II standard device for at least 12 hours every day, including the entire night and at least 2 hours during the day.
|
After being interviewed and provided by a doctor with two kinds of appliances (Activator and EF class II standard) for treating class II malocclusion, the patients choose their appliance.
The patients were separated into two groups (30 in each).
Group 1 was treated with an Activator appliance (Activator group), whereas Group 2 was treated with an EF class II standard appliance (EF line group)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To compare the clinical effectiveness of reducing severe overjet in Angle Class II division 1 malocclusion between Activator and the EF (Functional Education) class II standard in treating.
Time Frame: 6 months
|
Every month, the research participants from both groups underwent regular re-examinations, during which they collected cephalometric radiographs for assessment at two specific time points: T0, before treatment, and T1 after 6 months of treatment.
A Planmeca ProMax® 2D digital X-ray system (Planmeca, Poland) captured the cephalometric radiographs.
The Dental Hospital used the licensed AudaxCeph program to accurately draw lines and perform measurements on the cephalometric images.
|
6 months
|
Collaborators and Investigators
Investigators
- Study Director: Lam Nguyen Le, PhD, Can Tho University of Medicine and Pharmacy
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LamNguyenLe FOS-CTUMP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Class II Division 1 Malocclusion
-
Postgraduate Institute of Dental Sciences RohtakUnknownAngle Class II, Division 1 MalocclusionIndia
-
Postgraduate Institute of Dental Sciences RohtakRecruiting
-
Damascus UniversityCompletedCLASS II DIVISION 1 MALOCCLUSIONSyria
-
Vastra Gotaland RegionGöteborg University; Region Halland; Västra GötalandsregionenNot yet recruitingClass II Malocclusion | Class II Malocclusion, Division 1 | OverjetSweden
-
Damascus UniversityCompletedMalocclusion, Angle Class II, Division 1Syria
-
Faculty of Dental Medicine for GirlsCompletedMalocclusion, Angle Class II, Division 1Egypt
-
Sichuan UniversityCompletedCLASS II DIVISION 1 MALOCCLUSIONChina
-
Hesham Nabil Ali Al-QamhawyAl-Azhar UniversityRecruitingBimaxillary Protrusion | Malocclusion, Angle Class II, Division 1 | Class I MalocclusionEgypt
-
Bezmialem Vakif UniversityPEBS DENTAL CLINICRecruitingClass II Div 1 Malocclusion | Class III Malocclusion | Class II Division 2 Malocclusion | Class I MalocclusionTurkey (Türkiye)
-
Bezmialem Vakif UniversityCompletedClass II Malocclusion | Class II Malocclusion, Division 1Turkey
Clinical Trials on Skeletal, dental, soft tissue index changes in Activator group
-
Al-Azhar UniversityRecruiting
-
Ain Shams UniversityCompletedThrombolytic Therapy | Pulmonary Embolism Subacute MassiveEgypt
-
Rabin Medical CenterUnknown